Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Parasite Immunology

Redressing the Balance Against B Regulatory Cells: Novel Immunotherapeutic Target in Leishmaniasis

View Full Paper
Ask AI
Bookmark
Share

Authors

SDSunil Kumar DhatwaliaSSSheetal SharmaSKSukhbir Kaur

Discussion

Loading...

Member takes

Overview

Novel approach demonstrates potential to reprogram B regulatory cells in leishmaniasis, suggesting improved treatment outcomes.

Key Points

  • Targeting B regulatory cells may enhance the efficacy of immunotherapy for leishmaniasis.
  • Elevated IL-10 from B regulatory cells impairs Th1 differentiation, promoting parasite growth.
  • Recent studies highlight the promise of BTK and MEK inhibitors in modulating B regulatory cell functions.
  • Understanding the role of IL-10 producing B cells is vital for developing effective leishmaniasis treatments.

Cite This Study

Dhatwalia et al. (2025) studied this question.

synapsesocial.com/papers/68c23d81b210217d6478df4ehttps://doi.org/10.1111/pim.70024
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Step-by-step: the CD8 T cell journey in leishmaniasis2025
  2. 2Oral Treatment With Heat Shock Protein 65‐Producing <i>Lactococcus lactis</i> Induces Regulatory T Cells, Modulating Inflammatory Response in <i>Leishmania braziliensis</i> Infection2025
  3. 3Extracellular Vesicle Release from Immune Cells in Cutaneous Leishmaniasis: Modulation by Leishmania (V.) braziliensis and Reversal by Antimonial Therapy2025
  4. 4ApoA1-driven cholesterol efflux and macrophage polarization orchestrate T-cell differentiation towards controlling Leishmania donovani pathogenesis2025
  5. 5Unleashing the immune modulatory potential of Leishmania amazonensis-derived extracellular vesicles in American cutaneous leishmaniasis2025